Item 5. Other Information
Item 5. Other Information
Insider Trading Arrangements
During the three months ended September 30, 2024, none of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
24
Item 6. Exhibits
Exhibit No. Description
10.1 — Separation Agreement, dated September 13, 2024, with Jeffrey L. Wade (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated September 13, 2024 and incorporated by reference herein).
10.2 — Consulting Agreement, dated September 13, 2024, with Jeffrey L. Wade (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated September 13, 2024 and incorporated by reference herein).
*31.1
— Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.2
— Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*32.1
— Certification of Principal Executive and Principal Financial Officers Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
— XBRL Instance Document
101.SCH
— XBRL Taxonomy Extension Schema Document
101.CAL
— XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
— XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
— XBRL Taxonomy Extension Label Linkbase Document
101.PRE
— XBRL Taxonomy Extension Presentation Linkbase Document
104 — Cover Page Interactive Data File (embedded within the Inline XBRL document)
_____________________
* Filed herewith.
25
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Lexicon Pharmaceuticals, Inc.
Date: November 13, 2024 By: /s/ Michael S. Exton
Michael S. Exton, Ph.D.
Chief Executive Officer
Date: November 13, 2024 By: /s/ Kristen L. Alexander
Kristen L. Alexander
Vice President, Finance and Accounting
26
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.